Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Prevail Therapeutics Inc. (PRVL) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Prevail Therapeutics Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1714798.
Total stock buying since 2019: $816,407,704.
Total stock sales since 2019: $0.
Total stock option exercises since 2019: $658,979.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 34,284,789 | $771,407,752 | 0 | $0 | 0 | $0 |
| 2020 | 0 | $0 | 0 | $0 | 125,793 | $656,639 |
| 2019 | 2,647,056 | $44,999,952 | 0 | $0 | 13,000 | $2,340 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-01 | 34,284,789 | $771,407,752 | 0 | $0 | 0 | $0 |
| 2020-12 | 0 | $0 | 0 | $0 | 125,793 | $656,639 |
| 2019-12 | 0 | $0 | 0 | $0 | 13,000 | $2,340 |
| 2019-06 | 2,647,056 | $44,999,952 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-01-22 | Eli Lilly & Co (10% Owner) | Buy | 34,284,789 | 22.50 | 771,407,752 |
| 2020-12-30 | Abeliovich Asa (President & CEO) | Option Ex | 125,793 | 5.22 | 656,639 |
| 2019-12-24 | Minkow Emily (Chief Business Officer) | Option Ex | 13,000 | .18 | 2,340 |
| 2019-06-24 | Orbimed Capital Gp Vi Llc (Director) | Buy | 882,352 | 17.00 | 14,999,984 |
| 2019-06-24 | Thompson Peter A. (Director) | Buy | 882,352 | 17.00 | 14,999,984 |
| 2019-06-24 | Gordon Carl L (Director) | Buy | 882,352 | 17.00 | 14,999,984 |
Insider trading activities including stock purchases, stock sales, and option exercises of PRVL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Prevail Therapeutics Inc. (symbol PRVL, CIK number 1714798) see the Securities and Exchange Commission (SEC) website.